The Pricing Evolution of Personalized Medicines

Grant D. Lawless, RPh, MD, FACP

Video Categories: Pricing

Grant Lawless discusses the changing landscape of pricing personalized medicines
January 16, 2019

Navigating the CMS 14-Day Rule in Biomarker Testing

Drs. David Rimm and Roy Herbst review the problems with the CMS “14-Day Rule” since some of the multigene panel biomarker tests require 21 days or longer to complete.

December 12, 2016

New Effective Targets

Sunil Verma, MD, MSEd, FRCPC discusses new classes of therapies for HR+ Breast Cancer.